Search

Female rats treated with liothyronine or its solvent (control rats) were given an intravenous injection of [(14)C]-L-histidine. The amount of [(14)C]-histamine in various tissues was measured at 10 min, 60 min and 22 hr after the injection. In control rats the glandular stomach contained large amounts of [(14)C]-histamine at 10 and 60 min, with a sharp decline at 22 hr. The skin contained small amounts at 10 and 60 min, with a slight rise at 22 hr. In rats treated with liothyronine there was more [(14)C]-histamine in the stomach at 10 and 60 min, but not at 22 hr after the injection of [(14)C]-L-histidine. The results support the following conclusions: (1) The glandular stomach in the intact rat forms more histamine than do other tissues; the gastric histamine is in a rapid state of turnover and is likely to contribute substantially to the urinary output of histamine. (2) After treatment with liothyronine the rat has an increased histamine formation in the stomach; this is probably the main cause of the raised urinary histamine excretion in such a rat.

The excretion of histamine (Hi) and its metabolite methylhistamine (MeHi) was determined in separated fractions of urine up to 12h after standardized allergen provocations in 18 adult patients with defined extrinsic bronchial asthma. The main histamine metabolite, methylimidazoleacetic acid (MelmAA), was measured in six of the patients. After positive provocations (decrease in FEV1 > 20%) the excretion of Hi was significantly increased during 3h and that of MeHi during 4h after challenge. Negative provocations (decrease in FEV1 < 20%) were not followed by any changes in the excretion of Hi and Mehi. MelmAA excretion increased in five out of six patients after positive provocation. It was calculated that the increased excretion of Hi and its metabolites after a positive provocation corresponded to a release of about 1 mg histamine in the body or about 1 μg/g lung tissue if all histamine was liberated in the lung. Pretreatment with two anti-allergic drugs, disodium cromoglycate and ICI 74.917, giving significant allergen protection, resulted in a smaller increase of the excretion of both Hi and MeHi, indicating an inhibition of histamine release in vivo. [ABSTRACT FROM AUTHOR]

Histamine metabolism was investigated in patients with intrinsic asthma, during the acute phase and in remission, by determination of the urinary excretion of histamine metabolites. During acute attacks the excretion of methythistamine (MeHi) and 1- methyl-4-unidazoleacetic acid (MeImAA) was significantly increased compared with healthy subjects. The excretion of MeHi was significantly increased during acute attacks compared with remission. The excretion of MeImAA was also increased, but the difference was not significant. The correlation between the excretion of MeHi and MeImAA was highly significant, Corticosteroids, given to some patients during remission, did not affect the excretion of histamine and its metabolites. Smoking and respiratory infection during the acute attacks were both accompanied by increased excretion of MeHi, The results indicate that there is an increased histamine turnover in acute attacks of intrinsic bronchial asthma. [ABSTRACT FROM AUTHOR]